THYORA
LIVE

Serial Number

50024804

Owner

Thyora Therapeutics, Inc.

Attorney

Francis P. Cislak

Filing Date

Jul 31, 2026

Add to watchlist:

No watchlists yet
View on USPTO

THYORA Trademark

Serial Number: 50024804

THYORA is a trademark filed by Thyora Therapeutics, Inc. on July 31, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Thyora Therapeutics, Inc.

716 W Mount Airy Ave
Philadelphia, PA 19119

Entity Type: 03

Trademark Details

Filing Date

July 31, 2026

Registration Date

Not Registered

Goods & Services

Product research and development; Scientific research and development; Research and development of new products; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Consulting services in the field of pharmaceutical research and development; Research and development services in the field of medical preparations; Research and development services in the field of biotechnology; Research and development services in the field of pharmaceutical preparations; Research and development services of new pharmaceutical products; Research and development of medicines; Research and development in the field of pharmaceuticals; Research and development of new products in the field of pharmaceuticals; Research and development in the field of biomedicine; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the field of clinical trials; Pharmaceutical drug development services

Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical testing for diagnostic or treatment purposes; Medical testing services; Providing medical information, consultancy and advisory services

Chemical reagents for medical or veterinary purposes; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the treatment of infectious diseases; Reagents for medical use; Clinical medical reagents; Reagents for medical purposes; Biological reagents for medical use; Biochemical reagents for medical or veterinary purposes; Therapeutic pharmaceutical for the treatment of neurological diseases

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 31, 2026 MAFR
NEW APPLICATION ENTERED
Jul 31, 2026 NWAP